🔎 Trials Near Me

Home › Mieloma multiplo › North Carolina › Winston-Salem

Studi clinici su Mieloma multiplo a Winston-Salem, NC

14 studi su Mieloma multiplo cercano partecipanti presso sedi a Winston-Salem e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)

In reclutamentoFase 3
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07391657

A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

In reclutamentoFase 2
  • Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center, Winston-Salem
Età da 18 a 80 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07149857

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

In reclutamentoFase 2
  • Wake Forest University, School of Medicine Dept. of Internal Medicine, Division of Hematology Oncology, Winston-Salem
Età 60 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06052826

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

In reclutamentoFase 3
  • Novant Health Forsyth Medical Center, Winston-Salem
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05552222

A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

In reclutamentoFase 1/2
  • Wake Forest Baptist Health /ID# 271294, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06953960

Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma

In reclutamentoFase 3
  • Forsythe Memorial Hospital Inc., dba Novant Health Oncology Specialists, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07555938

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

In reclutamentoFase 3
  • Research Site, Winston-Salem
  • Research Site, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 ago 2026 · NCT07764978

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

In reclutamentoFase 1/2
  • Atrium Health Wake Forest Baptist Medical Center /ID# 274847, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 21 lug 2026 · NCT06892522

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

In reclutamentoFase 1
  • Atrium Health Wake Forest Baptist Medical Center /ID# 251165, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 lug 2026 · NCT05650632

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

In reclutamentoFase 1
  • Wake Forest University Health Sciences, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT05137054

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

In reclutamentoStudio osservazionale
  • Wake Forest Baptist Health, Winston-Salem
Età da 18 a 120 · Tutti i sessi · Aggiornato il 13 apr 2026 · NCT01890486

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

In reclutamentoFase 1/2
  • Atrium Wake Forest Baptist Medical Center, Winston-Salem
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 mar 2026 · NCT04988555

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

In reclutamentoFase 1/2
  • Atrium Health Wake Forest Baptist, Winston-Salem
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 giu 2025 · NCT06119685

Studi su Mieloma multiplo in altre città

Altri studi a Winston-Salem

Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.